Sankyo Company Limited

ACTIVATE

The wording ACTIVATE and the horizontal line behind the literal element appear in blue and the design of a heart appears in red.;The color(s) red and blue is/are claimed as a feature of the mark.;Pharmaceutical and scientific research; conducting clinical studies, trials and investigations;

ALOMETAN

PHARMACEUTICAL PREPARATIONS, NAMELY, CENTRAL NERVOUS SYSTEM DEPRESSANTS, ANTI-HISTAMINICS, CARDIOTONICS, PREPARATIONS FOR TREATING ARRHYTHMIA, DIURETICS, HYPOTENSORS, CEREBRAL HEMORRHAGE PROPHYLACTICS, ANTITUSSIVES AND EXPECTORANTS, STOMACHIS AND DIGESTIVES, ANTIACIDS, HORMONES, ANTI-INFLAMMATORY ANALGESICS, ANTI-ITCHING PREPARATIONS, CATAPLASMS, ANTICOAGULANTS, ANTI-SARCOMA PREPARATIONS, ANTI-CANCER PREPARATIONS, ANTIBIOTICS, ANTITUBERCULOTIC PREPARATIONS, VACCINES, ANTITOXINS, ANTIPROTOZOALS, ANTHELMINTICS, DRUGS FOR ARTERIOSCLEROSIS, ONCOSTATIC DRUGS, MULTIENZYME DIGESTANTS, ANTIPARKINSONISM, TRANQUILIZERS, ANTIANXIETY PREPARATIONS, VITAMINS, AND NUTRITIONAL FOOD SUPPLEMENTS; ALL PURPOSE DISINFECTANTS, RODENTICIDES, HERBICIDES;

ALOMETAN

pharmaceutical preparations, namely central nervous system depressants, anti-histaminics, cardiotonics, preparations for treating arrhythmia, diuretics, hypotensors, cerebal hemorrhage prophylactics, antitussives and expectorants, stomachics and digestives, antiacids, hormones, anti-inflammatory analgesics, anti-itching preparations, cataplasms, anticoagulants, anti-sarcoma preparations, anti-cancer preparations, antibiotics, antituberculotic preparations, vaccines, antitoxins, antiprotozoals, anthelmintics, drugs for arteriosclerosis, oncostatic drugs, multienzyme digestants, antiparkinsonism, tranquilizers, antianxiety preparations, vitamins, and nutritional food supplements; all purpose disinfectants, rodenticides and herbicides for domestic and/or agricultural use;

ANIDIM

pharmaceutical preparations for the treatment of blepharedema, chalazion, conjunctivitis, keratitis, cataracts, uveitis, retinitis, retinopathy and glaucoma in sensory organs, namely, eyes; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of urogenital diseases; and pharmaceutical preparations for the treatment of irregular or abnormal metabolism;

ANIDIM

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF POLYCYSTIC OVARY SYNDROME;

ANIDIM

Pharmaceutical preparations, namely, agents affecting the central nervous system, the peripheral nervous system, sensory organs, respiratory organs, and digestive organs; antiallergic agents; cardiovascular agents; hormones for medical purposes; urogenital and anal treatment agents; dermatological preparations; vitamins; nutritional supplements and dietary supplements containing amino acid preparations for medical use; nutritional supplements and dietary supplements containing calcium; nutritional supplements and dietary supplements containing chondroitin preparations; nutritional supplements and dietary supplements containing food enriching preparations; nutritional supplements and dietary supplements containing organotherapy preparations proteins, amino acids and their preparations, saccharide preparations, mineral preparations, medical alcohol beverages and organic preparations; agents for blood, namely anticoagulants, blood substitutes, blood-plasma and hemostatics; pharmaceutical preparations for treatment of metabolic conditions; tumor suppressing agents; agents for treating physically caused skin lesions; agents for treating chemically caused skin lesions; antibiotic preparations; chemotherapeutic agents; biological preparations namely clinical reagents for medical purposes comprising antibacterial sera, antitoxins, mixed biological preparations, diagnostic aids for biological tests, toxoids, toxins and vaccines; parasiticides for domestic, agricultural and medical use; diagnostic preparations for medical laboratory use; veterinary preparations namely agents affecting the central nervous systems, the peripheral nervous system and the digestive organs, cardiovascular agents; hormones for medical purposes; vitamins; veterinary preparations for treatment of metabolic conditions; antibiotic preparations, biological preparations, namely clinical reagents for medical purposes; mosquito-repellent incenses; general purpose germicides; fungicides, insecticides, pesticides all for agricultural and domestic use; fumigants and herbicides all for agricultural and domestic use; room deodorants not for personal use; insect repellents; mothproofing preparations, namely moth balls; antiseptics;

ANIDIM

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dislipidemia, blood disorders, metabolic disorders, endocrinoses, including diabetes, and their complications, polycystic ovarian syndrome, cancer, autoimmune diseases, bacterial infection, viral infection, inflammation and inflammatory diseases, musculoskeletal disorders, pain;

APRES

The English translation of the word APRES is after.;Pharmaceutical and scientific research; conducting clinical studies, trials and investigations;

AZOR

pharmaceutical preparations, namely, pravastatin sodium and preparations made thereof, for use in reducing cholesterol;

AZOR

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, namely hyperlipidemia, atherosclerosis, myocardial infarction, angina pectoris and stroke and cholesterol reduction.;

BANAN

ANTIBIOTICS AND PREPARATIONS THEREOF;BANANA;

BANAN

antibiotics and preparations thereof;

BENEVAS

OLMESARTAN MEDOXOMIL AND OLMESARTAN MEDOXOMIL/ HYDROCHLOROTHIIAZIDE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES INCLUDING HIGH BLOOD PRESSURE, CONGESTIVE HEART FAILURE, DIABETIC NEPHROPATHY ATHEROSCLEROSIS AND STROKE ANGIOTENSIN II RECEPTOR ANTAGONIST;

BENEVAS

Pharmaceutical preparations for the treatment of cardiovascular diseases including high blood pressure, congestive heart failure, diabetic nephropathy, atherosclerosis and stroke;

BENEVAS HCT

Olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide for the treatment of cardiovascular diseases including high blood pressure, congestive heart failure, diabetic nephropathy, atherosclerosis and stroke;HCT;